TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE)

CourtNew Jersey Superior Court Appellate Division
DecidedDecember 26, 2019
DocketA-4092-18T1
StatusUnpublished

This text of TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE) (TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE)) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE), (N.J. Ct. App. 2019).

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-4092-18T1

TOX DESIGN GROUP, LLC,

Plaintiff,

v.

RA PAIN SERVICES, PA,

Defendant/Third-Party Plaintiff/Respondent,

CENTRAL TOX, LLC, MICHAEL SCHMITT, GREGORY KAPLAN, BARRY CHAFFIN, and GARY BUCK,

Third-Party Defendants,

and

@MEDICAL LLC, and CHRISTOPHER RYAN HERTING,

Third-Party Defendants/ Appellants. __________________________________

Argued November 12, 2019 - Decided December 26, 2019 Before Judges Sumners and Geiger.

On appeal from the Superior Court of New Jersey, Law Division, Camden County, Docket No. L-1485-18.

Michael William Bootier argued the cause for appellants AtMedicalCo, LLC and Christopher Ryan Herting (Buchanan Ingersoll & Rooney PC, attorneys; Michael William Bootier and Shane P. Simon, on the briefs).

Christopher L. Soriano argued the cause for respondent RA Pain Services, PA (Duane Morris, LLP, attorneys; Christopher L. Soriano and Samantha L. Haggerty, of counsel and on the brief).

PER CURIAM

Third-party defendants AtMedicalCo, LLC1 (AtMedical) and Christopher

Ryan Herting, its Chief Executive Officer (collectively the AtMedical

Defendants), appeal from an April 12, 2019 Law Division order denying their

motion to compel binding arbitration and stay the third-party action filed by

defendant/third-party plaintiff RA Pain Services, P.A. (RA Pain) pending the

outcome of the arbitration. For the following reasons, we reverse and remand.

1 Improperly pleaded as @Medical, LLC. A-4092-18T1 2 I.

RA Pain owns and operates an independent clinical laboratory that

provides toxicology and drug testing, medication monitoring, pharmacogenetic

testing, and other laboratory services. It sought to engage a manager to provide

management and operational services for its laboratory, including billing and

collection, finance and accounting, implementation of an information

management system, and laboratory design and setup.

On November 2, 2016, RA Pain entered into a Lab Management Services

Agreement (LMSA) with AtMedical to provide management and operational

services for its laboratory. The LMSA was executed on behalf of RA Pain by

its Chief Executive Officer and managing shareholder, Gary Buck, M.D., and

on behalf of AtMedical by its Chief Executive Officer, Herting. RA Pain

operates in both New Jersey and Pennsylvania while AtMedical operates only

in Pennsylvania.

The LMSA contained arbitration and forum selection clauses. Paragraph

fifteen of the LMSA (the Forum Selection Clause) states:

Governing Law. This Agreement shall be deemed to have been made and shall be construed and interpreted in accordance with the laws of the State of New Jersey without regard to the state's conflict of laws provisions. All litigation, claims and actions for the enforcement of this Agreement or otherwise related to this Agreement

A-4092-18T1 3 shall commenced only in the State or Federal courts located in Camden County, New Jersey, and each of the parties hereto expressly submits to the personal jurisdiction of such courts in any such litigation.

[(Emphasis added).]

Paragraph thirty-two of the LMSA (the Arbitration Clause) states:

Resolution of Disputes. In the event that a dispute arises between two or more Parties under this Agreement or regarding the subject matter of this Agreement, the Parties will first negotiate in good faith for up to thirty (30) days to try and resolve the dispute. If the dispute cannot be settled through negotiation within thirty (30) days, such dispute shall be settled by final and binding arbitration to be conducted in Philadelphia, Pennsylvania by one arbitrator with at least ten (10) years of experience in health care matters, such arbitration to be conducted in accordance with the commercial arbitration rules of the American Arbitration Association ("AAA").

AAA Rule 7 was expressly incorporated into the LMSA. It sets forth the

broad jurisdiction of the arbitrator. Subsection (a) of the rule provides:

The arbitrator shall have the power to rule on his or her own jurisdiction, including any objections with respect to the existence, scope, or validity of the arbitration agreement or to the arbitrability of any claim or counterclaim.

Subsection (b) of the rule provides:

A-4092-18T1 4 The arbitrator shall have the power to determine the existence or validity of a contract of which an arbitration clause forms a part. Such an arbitration clause shall be treated as an agreement independent of the other terms of the contract. A decision by the arbitrator that the contract is null and void shall not for that reason alone render invalid the arbitration clause.

RA Pain was subsequently named as a defendant in an action brought by

plaintiff Tox Design Group, LLC. RA Pain, in turn, filed a second amended

answer and third-party action against the AtMedical Defendants and six other

third-party defendants, including Buck. The third-party complaint alleged the

AtMedical Defendants were liable for: (1) civil conspiracy (count I); (2) aiding

and abetting breach of fiduciary duty (count IV); (3) breach of the LMSA (count

XII); (4) breach of the covenant of good faith and fair dealing (count XIII); (5)

promissory estoppel (count XIV); (6) unjust enrichment (count XV); and (7)

negligence (count XVI).2

The AtMedical Defendants moved to compel binding arbitration of the

claims asserted by RA Pain and stay the third-party action pending the outcome

of the arbitration. They contended that the Arbitration Clause required RA Pain

to submit its claims to binding arbitration. The AtMedical Defendants further

2 The remaining counts pertain to claims against other third-party defendants not involved in this appeal. A-4092-18T1 5 contended that the Forum Selection Clause is "essentially . . . a fallback

provision to the arbitration provision" that would be used "in the event that the

arbitration is unsuccessful." By way of example, they aver that the Forum

Selection Clause requires applications to enforce arbitration subpoenas and

awards to be filed in the state or federal court in Camden County. The

AtMedical Defendants further argued that when parties incorporate the AAA

rules into a contract, the AAA rules "become express terms of the contract

itself." They pointed to the headings listed in the LMSA: the Forum Selection

Clause falls under "Governing Law," while the Arbitration Clause falls under

"Resolution of Disputes."

The AtMedical Defendants emphasize that the LMSA was a contract

between two sophisticated commercial entities, not individual consumers. They

therefore contend that the enhanced waiver of rights language requirement

imposed on consumer contract arbitration provisions do not apply to the LMSA.

Finally, the AtMedical Defendants contend RA Pain provided no facts for

the motion court to consider with respect to the validity of the agreement. It

submitted no affidavit or certification from any member or representative of RA

Pain attesting to any underlying facts. Accordingly, the motion court could not

consider the facts asserted in the unsworn statement of counsel.

A-4092-18T1 6 RA Pain opposed the motion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Howsam v. Dean Witter Reynolds, Inc.
537 U.S. 79 (Supreme Court, 2002)
Green Tree Financial Corp. v. Bazzle
539 U.S. 444 (Supreme Court, 2003)
Preston v. Ferrer
552 U.S. 346 (Supreme Court, 2008)
Rockel v. Cherry Hill Dodge
847 A.2d 621 (New Jersey Superior Court App Division, 2004)
Linden Board of Education v. Linden Education Ass'n
997 A.2d 185 (Supreme Court of New Jersey, 2010)
Griffin v. BURLINGTON VOLKSWAGEN
988 A.2d 101 (New Jersey Superior Court App Division, 2010)
Curtis v. Cellco Partnership
992 A.2d 795 (New Jersey Superior Court App Division, 2010)
New Jersey Turnpike Authority v. Local 196, I.F.P.T.E.
920 A.2d 88 (Supreme Court of New Jersey, 2007)
Leodori v. Cigna Corp.
814 A.2d 1098 (Supreme Court of New Jersey, 2003)
Delta Funding Corp. v. Harris
912 A.2d 104 (Supreme Court of New Jersey, 2006)
GMAC v. Pittella
17 A.3d 177 (Supreme Court of New Jersey, 2011)
Patricia Atalese v. U.S. Legal Services Group, L.P. (072314)
99 A.3d 306 (Supreme Court of New Jersey, 2014)
Chesapeake Appalachia, LLC v. Scout Petroleum, LLC
809 F.3d 746 (Third Circuit, 2016)
Annemarie Morgan v. Sanford Brown Institute(075074)
137 A.3d 1168 (Supreme Court of New Jersey, 2016)
Henry Schein, Inc. v. Archer & White Sales, Inc.
586 U.S. 63 (Supreme Court, 2019)
Gar Disability Advocates, LLC v. Taylor
365 F. Supp. 3d 522 (D. New Jersey, 2019)
Angrisani v. Financial Technology Ventures
952 A.2d 1140 (New Jersey Superior Court App Division, 2008)
NAACP of Camden County East v. Foulke Management Corp.
24 A.3d 777 (New Jersey Superior Court App Division, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
TOX DESIGN GROUP, LLC VS. RA PAIN SERVICES, PA VS. CENTRAL TOX, LLC (L-1485-18, CAMDEN COUNTY AND STATEWIDE), Counsel Stack Legal Research, https://law.counselstack.com/opinion/tox-design-group-llc-vs-ra-pain-services-pa-vs-central-tox-llc-njsuperctappdiv-2019.